scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YGYNO.2005.05.003 |
P698 | PubMed publication ID | 15982726 |
P2093 | author name string | Elizabeth A Gray | |
William T Creasman | |||
Matthew Kohler | |||
Rajesh S Mathur | |||
Subbi P Mathur | |||
Derrick Lane | |||
Paul G Underwood | |||
P2860 | cites work | Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis | Q24669710 |
VEGF-C mediates cyclic pressure-induced endothelial cell proliferation | Q28208643 | ||
Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells | Q28211849 | ||
Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis | Q33202253 | ||
Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma | Q35041319 | ||
Lymphangiogenesis and tumor metastasis | Q35186253 | ||
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis | Q35805972 | ||
A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer | Q36646055 | ||
Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer. | Q36671720 | ||
Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers | Q36695475 | ||
Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers | Q40442727 | ||
In vitro downregulation of growth factors by insulin-like growth factor binding protein-3 in cervical cancer | Q40619644 | ||
Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D. | Q40712610 | ||
Expression and significance of VEGF-C and FLT-4 in gastric cancer. | Q42005916 | ||
Insulin-like growth factor II in gynecological cancers: a preliminary study | Q43486612 | ||
Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines | Q45280006 | ||
Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors | Q46516597 | ||
Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma | Q47727271 | ||
Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. | Q53615125 | ||
Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer. | Q54781946 | ||
Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis | Q59607660 | ||
Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer | Q73184364 | ||
Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer | Q73725413 | ||
Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors | Q73853983 | ||
Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery | Q74492639 | ||
Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival | Q77753199 | ||
Lymphangiogenesis and tumor metastasis | Q79092311 | ||
Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer | Q79366823 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cervix uterine cancer | Q160105 |
biomarker | Q864574 | ||
P304 | page(s) | 467-483 | |
P577 | publication date | 2005-09-01 | |
P1433 | published in | Gynecologic Oncology | Q5625182 |
P1476 | title | Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. | |
P478 | volume | 98 |
Q34112190 | Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer |
Q37156639 | Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? |
Q53611411 | Clinical significance of RCAS1 as a biomarker of uterine cancer. |
Q38304904 | Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): novel marker for cervical carcinogenesis |
Q34795458 | Effects of a nutrient mixture on immunohistochemical localization of cancer markers in human cervical cancer HeLa cell tumor xenografts in female nude mice |
Q36612618 | First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours |
Q84190566 | Lymphangiogenesis and cancer metastasis |
Q34351507 | PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. |
Q36137715 | Resistive-Pulse Measurements with Nanopipettes: Detection of Vascular Endothelial Growth Factor C (VEGF-C) Using Antibody-Decorated Nanoparticles |
Q37328423 | Serum biomarkers for early detection of gynecologic cancers |
Q57788704 | Serum vascular endothelial growth factor-C levels predict lymph node metastasis and prognosis of patients with gallbladder cancer |
Q84701414 | Serum vascular endothelial growth factors a, C and d in human breast tumors |
Q36265146 | Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits |
Q36901201 | VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis |
Q45212474 | Vascular endothelial growth factor C expression is closely correlated with lymph node recurrence and poor prognosis in patients with early stage cervical cancer |
Q46119200 | Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism |
Q39457372 | Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. |